Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 13, 2019

SELL
$89.51 - $118.04 $1.79 Million - $2.36 Million
-20,000 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $855,324 - $1.33 Million
-13,800 Reduced 40.83%
20,000 $1.73 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $816,101 - $1.36 Million
16,900 Added 100.0%
33,800 $2.67 Million
Q2 2018

Aug 13, 2018

SELL
$37.84 - $69.96 $2.27 Million - $4.2 Million
-60,000 Reduced 78.02%
16,900 $1.01 Million
Q1 2018

May 14, 2018

BUY
$39.82 - $57.53 $3.06 Million - $4.42 Million
76,900 New
76,900 $3.1 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Brant Point Investment Management LLC Portfolio

Follow Brant Point Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brant Point Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brant Point Investment Management LLC with notifications on news.